Seer Inc (NASDAQ: SEER) stock jumped 2.04% on Friday to $1.50 against a previous-day closing price of $1.47. With 0.9 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.32 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.5350 whereas the lowest price it dropped to was $1.4700. The 52-week range on SEER shows that it touched its highest point at $7.39 and its lowest point at $1.46 during that stretch. It currently has a 1-year price target of $10.00. Beta for the stock currently stands at 1.48.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SEER was down-trending over the past week, with a drop of -3.85%, but this was down by -18.92% over a month. Three-month performance dropped to -38.78% while six-month performance fell -60.42%. The stock lost -79.89% in the past year, while it has lost -74.14% so far this year. A look at the trailing 12-month EPS for SEER yields -1.43 with Next year EPS estimates of -1.32. For the next quarter, that number is -0.36. This implies an EPS growth rate of 3.67% for this year and 8.08% for next year. EPS is expected to decline by -11.70% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -94.75%.
Float and Shares Shorts:
At present, 59.37 million SEER shares are outstanding with a float of 41.90 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.56 million, which was 2.44% higher than short shares on Sep 28, 2023. In addition to Dr. Omid C. Farokhzad M.D., Ph.D. as the firm’s Founder, President, CEO & Chair of the Board of Directors, Mr. David R. Horn serves as its Executive VP, Treasurer & CFO.
Through their ownership of 79.71% of SEER’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 31.11% of SEER, in contrast to 26.02% held by mutual funds. Shares owned by individuals account for 20.08%. As the largest shareholder in SEER with 9.93% of the stake, Fidelity Management & Research Co holds 5,946,579 shares worth 5,946,579. A second-largest stockholder of SEER, Invus Public Equities Advisors LL, holds 4,750,000 shares, controlling over 7.93% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in SEER, holding 4,113,968 shares or 6.87% stake. With a 6.85% stake in SEER, the American Funds Small Cap World Fu is the largest stakeholder. A total of 4,102,472 shares are owned by the mutual fund manager. The Fidelity Select Medical Technolog, which owns about 4.68% of SEER stock, is the second-largest Mutual Fund holder. It holds 2,800,000 shares valued at 4.59 million. Vanguard Total Stock Market ETF holds 2.50% of the stake in SEER, owning 1,499,055 shares worth 2.46 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SEER since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SEER analysts setting a high price target of $10.00 and a low target of $10.00, the average target price over the next 12 months is $10.00. Based on these targets, SEER could surge 566.67% to reach the target high and rise by 566.67% to reach the target low. Reaching the average price target will result in a growth of 566.67% from current levels.
Summary of Insider Activity:
Insiders traded SEER stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 40,000 shares were bought while 0 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 10 over the past year. The total number of shares bought during that period was 839,544 while 69,799 shares were sold.